bumetanide has been researched along with Liver Neoplasms in 1 studies
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Most types of tumors, including hepatocellular carcinoma (HCC), are heterogeneous in terms of genotype and phenotype." | 2.53 | Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas. ( Chen, R; Ding, G; Dong, J; Fu, H; Fu, Z; Guo, M; Guo, W; Liu, F; Sun, K; Teng, F; Wang, C; Zhang, L; Zou, Y, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teng, F | 1 |
| Guo, M | 1 |
| Liu, F | 1 |
| Wang, C | 1 |
| Dong, J | 1 |
| Zhang, L | 1 |
| Zou, Y | 1 |
| Chen, R | 1 |
| Sun, K | 1 |
| Fu, H | 1 |
| Fu, Z | 1 |
| Guo, W | 1 |
| Ding, G | 1 |
1 review available for bumetanide and Liver Neoplasms
| Article | Year |
|---|---|
Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas.
Topics: Animals; Bumetanide; Carcinoma, Hepatocellular; Databases, Genetic; Humans; Liver Neoplasms; Mice; S | 2016 |